Ikarian Capital, LLC Bicycle Therapeutics PLC Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $77,221 - $116,830	-4,075 Reduced 1.97%	203,037 $5.18 Million
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $4.15 Million - $6.5 Million	207,112 New	207,112 $4.41 Million
Q2 2022 Aug 12, 2022	SELL	$12.95 - $46.99 $6.2 Million - $22.5 Million	-478,784 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$40.12 - $59.5 $5.39 Million - $7.99 Million	-134,342 Reduced 21.91%	478,784 $21 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $3.61 Million - $5.3 Million	86,626 Added 16.45%	613,126 $37.3 Million
Q3 2021 Nov 15, 2021	BUY	$27.95 - $44.24 $14.7 Million - $23.3 Million	526,500 New	526,500 $21.9 Million

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.